ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hepatitis B Vaccines Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-30R3489
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hepatitis B Vaccines Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Hepatitis B Vaccines Market Research Report 2024

Code: QYRE-Auto-30R3489
Report
September 2024
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
NCPC
Merck
Bio Kangtai
Dynavax
KM Biologics
LG Life Sciences
Serum Institute
AIM Vaccine

Hepatitis B Vaccines Market Size

The global Hepatitis B Vaccines market was valued at US$ 1269 million in 2023 and is anticipated to reach US$ 1985 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.

Hepatitis B Vaccines Market

Hepatitis B Vaccines Market

Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.
Global key players of Hepatitis B Vaccines include GSK, Dynavax, NCPC, etc. The top three players hold a share about 64%. North America is the largest market for Hepatitis B Vaccines, which has a share about 45%, followed by Asia-Pacific and Europe with share 31% and 17%, separately. In terms of product type, Yeast Derived is the largest segment, occupied for a share of 85%. In terms of application, Adult is the largest field with a share about 64%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccines.
The Hepatitis B Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Hepatitis B Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hepatitis B Vaccines Market Report

Report Metric Details
Report Name Hepatitis B Vaccines Market
Accounted market size in 2023 US$ 1269 million
Forecasted market size in 2030 US$ 1985 million
CAGR 6.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Yeast Derived
  • CHO Derived
Segment by Application
  • Children
  • Adult
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, NCPC, Merck, Bio Kangtai, Dynavax, AIM Vaccine, KM Biologics, LG Life Sciences, Serum Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hepatitis B Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Hepatitis B Vaccines Market growing?

Ans: The Hepatitis B Vaccines Market witnessing a CAGR of 6.5% during the forecast period 2024-2030.

What is the Hepatitis B Vaccines Market size in 2030?

Ans: The Hepatitis B Vaccines Market size in 2030 will be US$ 1985 million.

What is the market share of major companies in Hepatitis B Vaccines Market?

Ans: The top three players hold a share about 64%.

What is the Hepatitis B Vaccines Market share by region?

Ans: North America is the largest market for Hepatitis B Vaccines, which has a share about 45%, followed by Asia-Pacific and Europe with share 31% and 17%, separately.

What is the Hepatitis B Vaccines Market share by type?

Ans: In terms of product type, Yeast Derived is the largest segment, occupied for a share of 85%.

What is the Hepatitis B Vaccines Market share by application?

Ans: In terms of application, Adult is the largest field with a share about 64%.

Who are the main players in the Hepatitis B Vaccines Market report?

Ans: The main players in the Hepatitis B Vaccines Market are GSK, NCPC, Merck, Bio Kangtai, Dynavax, AIM Vaccine, KM Biologics, LG Life Sciences, Serum Institute

What are the Application segmentation covered in the Hepatitis B Vaccines Market report?

Ans: The Applications covered in the Hepatitis B Vaccines Market report are Children, Adult

What are the Type segmentation covered in the Hepatitis B Vaccines Market report?

Ans: The Types covered in the Hepatitis B Vaccines Market report are Yeast Derived, CHO Derived

1 Hepatitis B Vaccines Market Overview
1.1 Product Definition
1.2 Hepatitis B Vaccines by Type
1.2.1 Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Hepatitis B Vaccines by Application
1.3.1 Global Hepatitis B Vaccines Market Value by Application (2024-2030)
1.3.2 Children
1.3.3 Adult
1.4 Global Hepatitis B Vaccines Market Size Estimates and Forecasts
1.4.1 Global Hepatitis B Vaccines Revenue 2019-2030
1.4.2 Global Hepatitis B Vaccines Sales 2019-2030
1.4.3 Global Hepatitis B Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hepatitis B Vaccines Market Competition by Manufacturers
2.1 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hepatitis B Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Hepatitis B Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hepatitis B Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis B Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Hepatitis B Vaccines, Date of Enter into This Industry
2.8 Global Hepatitis B Vaccines Market Competitive Situation and Trends
2.8.1 Global Hepatitis B Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hepatitis B Vaccines Players Market Share by Revenue
2.8.3 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hepatitis B Vaccines Market Scenario by Region
3.1 Global Hepatitis B Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hepatitis B Vaccines Sales by Region: 2019-2030
3.2.1 Global Hepatitis B Vaccines Sales by Region: 2019-2024
3.2.2 Global Hepatitis B Vaccines Sales by Region: 2025-2030
3.3 Global Hepatitis B Vaccines Revenue by Region: 2019-2030
3.3.1 Global Hepatitis B Vaccines Revenue by Region: 2019-2024
3.3.2 Global Hepatitis B Vaccines Revenue by Region: 2025-2030
3.4 North America Hepatitis B Vaccines Market Facts & Figures by Country
3.4.1 North America Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hepatitis B Vaccines Sales by Country (2019-2030)
3.4.3 North America Hepatitis B Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hepatitis B Vaccines Market Facts & Figures by Country
3.5.1 Europe Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hepatitis B Vaccines Sales by Country (2019-2030)
3.5.3 Europe Hepatitis B Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis B Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Hepatitis B Vaccines Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hepatitis B Vaccines Sales by Region (2019-2030)
3.6.3 Asia Pacific Hepatitis B Vaccines Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hepatitis B Vaccines Market Facts & Figures by Country
3.7.1 Latin America Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hepatitis B Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Hepatitis B Vaccines Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis B Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hepatitis B Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hepatitis B Vaccines Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis B Vaccines Sales by Type (2019-2030)
4.1.1 Global Hepatitis B Vaccines Sales by Type (2019-2024)
4.1.2 Global Hepatitis B Vaccines Sales by Type (2025-2030)
4.1.3 Global Hepatitis B Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Hepatitis B Vaccines Revenue by Type (2019-2030)
4.2.1 Global Hepatitis B Vaccines Revenue by Type (2019-2024)
4.2.2 Global Hepatitis B Vaccines Revenue by Type (2025-2030)
4.2.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Hepatitis B Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hepatitis B Vaccines Sales by Application (2019-2030)
5.1.1 Global Hepatitis B Vaccines Sales by Application (2019-2024)
5.1.2 Global Hepatitis B Vaccines Sales by Application (2025-2030)
5.1.3 Global Hepatitis B Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Hepatitis B Vaccines Revenue by Application (2019-2030)
5.2.1 Global Hepatitis B Vaccines Revenue by Application (2019-2024)
5.2.2 Global Hepatitis B Vaccines Revenue by Application (2025-2030)
5.2.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Hepatitis B Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Hepatitis B Vaccines Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 NCPC
6.2.1 NCPC Company Information
6.2.2 NCPC Description and Business Overview
6.2.3 NCPC Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 NCPC Hepatitis B Vaccines Product Portfolio
6.2.5 NCPC Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Hepatitis B Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Bio Kangtai
6.4.1 Bio Kangtai Company Information
6.4.2 Bio Kangtai Description and Business Overview
6.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio Kangtai Hepatitis B Vaccines Product Portfolio
6.4.5 Bio Kangtai Recent Developments/Updates
6.5 Dynavax
6.5.1 Dynavax Company Information
6.5.2 Dynavax Description and Business Overview
6.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dynavax Hepatitis B Vaccines Product Portfolio
6.5.5 Dynavax Recent Developments/Updates
6.6 AIM Vaccine
6.6.1 AIM Vaccine Company Information
6.6.2 AIM Vaccine Description and Business Overview
6.6.3 AIM Vaccine Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AIM Vaccine Hepatitis B Vaccines Product Portfolio
6.6.5 AIM Vaccine Recent Developments/Updates
6.7 KM Biologics
6.7.1 KM Biologics Company Information
6.7.2 KM Biologics Description and Business Overview
6.7.3 KM Biologics Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 KM Biologics Hepatitis B Vaccines Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 LG Life Sciences
6.8.1 LG Life Sciences Company Information
6.8.2 LG Life Sciences Description and Business Overview
6.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 LG Life Sciences Hepatitis B Vaccines Product Portfolio
6.8.5 LG Life Sciences Recent Developments/Updates
6.9 Serum Institute
6.9.1 Serum Institute Company Information
6.9.2 Serum Institute Description and Business Overview
6.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Serum Institute Hepatitis B Vaccines Product Portfolio
6.9.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis B Vaccines Industry Chain Analysis
7.2 Hepatitis B Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis B Vaccines Production Mode & Process
7.4 Hepatitis B Vaccines Sales and Marketing
7.4.1 Hepatitis B Vaccines Sales Channels
7.4.2 Hepatitis B Vaccines Distributors
7.5 Hepatitis B Vaccines Customers
8 Hepatitis B Vaccines Market Dynamics
8.1 Hepatitis B Vaccines Industry Trends
8.2 Hepatitis B Vaccines Market Drivers
8.3 Hepatitis B Vaccines Market Challenges
8.4 Hepatitis B Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
NCPC
Merck
Bio Kangtai
Dynavax
KM Biologics
LG Life Sciences
Serum Institute
AIM Vaccine
List of Tables
 Table 1. Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Hepatitis B Vaccines Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Hepatitis B Vaccines Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Hepatitis B Vaccines Sales (M Doses) of Key Manufacturers (2019-2024)
 Table 5. Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Hepatitis B Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Hepatitis B Vaccines Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Hepatitis B Vaccines Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Hepatitis B Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hepatitis B Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hepatitis B Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Hepatitis B Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccines as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Hepatitis B Vaccines Sales by Region (2019-2024) & (M Doses)
 Table 18. Global Hepatitis B Vaccines Sales Market Share by Region (2019-2024)
 Table 19. Global Hepatitis B Vaccines Sales by Region (2025-2030) & (M Doses)
 Table 20. Global Hepatitis B Vaccines Sales Market Share by Region (2025-2030)
 Table 21. Global Hepatitis B Vaccines Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Hepatitis B Vaccines Revenue Market Share by Region (2019-2024)
 Table 23. Global Hepatitis B Vaccines Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Hepatitis B Vaccines Revenue Market Share by Region (2025-2030)
 Table 25. North America Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
 Table 27. North America Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
 Table 28. North America Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
 Table 32. Europe Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
 Table 33. Europe Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Hepatitis B Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Hepatitis B Vaccines Sales by Region (2019-2024) & (M Doses)
 Table 37. Asia Pacific Hepatitis B Vaccines Sales by Region (2025-2030) & (M Doses)
 Table 38. Asia Pacific Hepatitis B Vaccines Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Hepatitis B Vaccines Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
 Table 42. Latin America Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
 Table 43. Latin America Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Hepatitis B Vaccines Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
 Table 47. Middle East and Africa Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
 Table 48. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Hepatitis B Vaccines Sales (M Doses) by Type (2019-2024)
 Table 51. Global Hepatitis B Vaccines Sales (M Doses) by Type (2025-2030)
 Table 52. Global Hepatitis B Vaccines Sales Market Share by Type (2019-2024)
 Table 53. Global Hepatitis B Vaccines Sales Market Share by Type (2025-2030)
 Table 54. Global Hepatitis B Vaccines Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Hepatitis B Vaccines Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2024)
 Table 57. Global Hepatitis B Vaccines Revenue Market Share by Type (2025-2030)
 Table 58. Global Hepatitis B Vaccines Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Hepatitis B Vaccines Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Hepatitis B Vaccines Sales (M Doses) by Application (2019-2024)
 Table 61. Global Hepatitis B Vaccines Sales (M Doses) by Application (2025-2030)
 Table 62. Global Hepatitis B Vaccines Sales Market Share by Application (2019-2024)
 Table 63. Global Hepatitis B Vaccines Sales Market Share by Application (2025-2030)
 Table 64. Global Hepatitis B Vaccines Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Hepatitis B Vaccines Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2024)
 Table 67. Global Hepatitis B Vaccines Revenue Market Share by Application (2025-2030)
 Table 68. Global Hepatitis B Vaccines Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Hepatitis B Vaccines Price (US$/Dose) by Application (2025-2030)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. GSK Hepatitis B Vaccines Product
 Table 74. GSK Recent Developments/Updates
 Table 75. NCPC Company Information
 Table 76. NCPC Description and Business Overview
 Table 77. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. NCPC Hepatitis B Vaccines Product
 Table 79. NCPC Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. Merck Hepatitis B Vaccines Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Bio Kangtai Company Information
 Table 86. Bio Kangtai Description and Business Overview
 Table 87. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Bio Kangtai Hepatitis B Vaccines Product
 Table 89. Bio Kangtai Recent Developments/Updates
 Table 90. Dynavax Company Information
 Table 91. Dynavax Description and Business Overview
 Table 92. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. Dynavax Hepatitis B Vaccines Product
 Table 94. Dynavax Recent Developments/Updates
 Table 95. AIM Vaccine Company Information
 Table 96. AIM Vaccine Description and Business Overview
 Table 97. AIM Vaccine Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 98. AIM Vaccine Hepatitis B Vaccines Product
 Table 99. AIM Vaccine Recent Developments/Updates
 Table 100. KM Biologics Company Information
 Table 101. KM Biologics Description and Business Overview
 Table 102. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 103. KM Biologics Hepatitis B Vaccines Product
 Table 104. KM Biologics Recent Developments/Updates
 Table 105. LG Life Sciences Company Information
 Table 106. LG Life Sciences Description and Business Overview
 Table 107. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 108. LG Life Sciences Hepatitis B Vaccines Product
 Table 109. LG Life Sciences Recent Developments/Updates
 Table 110. Serum Institute Company Information
 Table 111. Serum Institute Description and Business Overview
 Table 112. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 113. Serum Institute Hepatitis B Vaccines Product
 Table 114. Serum Institute Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Hepatitis B Vaccines Distributors List
 Table 118. Hepatitis B Vaccines Customers List
 Table 119. Hepatitis B Vaccines Market Trends
 Table 120. Hepatitis B Vaccines Market Drivers
 Table 121. Hepatitis B Vaccines Market Challenges
 Table 122. Hepatitis B Vaccines Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hepatitis B Vaccines
 Figure 2. Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Hepatitis B Vaccines Market Share by Type: 2023 & 2030
 Figure 4. Yeast Derived Product Picture
 Figure 5. CHO Derived Product Picture
 Figure 6. Global Hepatitis B Vaccines Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Hepatitis B Vaccines Market Share by Application: 2023 & 2030
 Figure 8. Children
 Figure 9. Adult
 Figure 10. Global Hepatitis B Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Hepatitis B Vaccines Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Hepatitis B Vaccines Sales (2019-2030) & (M Doses)
 Figure 13. Global Hepatitis B Vaccines Average Price (US$/Dose) & (2019-2030)
 Figure 14. Hepatitis B Vaccines Report Years Considered
 Figure 15. Hepatitis B Vaccines Sales Share by Manufacturers in 2023
 Figure 16. Global Hepatitis B Vaccines Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Hepatitis B Vaccines Players: Market Share by Revenue in Hepatitis B Vaccines in 2023
 Figure 18. Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
 Figure 21. North America Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
 Figure 22. U.S. Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
 Figure 25. Europe Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Hepatitis B Vaccines Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Region (2019-2030)
 Figure 33. China Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Indonesia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Thailand Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Malaysia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Philippines Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Hepatitis B Vaccines by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Hepatitis B Vaccines by Type (2019-2030)
 Figure 54. Global Hepatitis B Vaccines Price (US$/Dose) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Hepatitis B Vaccines by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Hepatitis B Vaccines by Application (2019-2030)
 Figure 57. Global Hepatitis B Vaccines Price (US$/Dose) by Application (2019-2030)
 Figure 58. Hepatitis B Vaccines Value Chain
 Figure 59. Hepatitis B Vaccines Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions